v3.26.1
Equity-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Payment Arrangement, Option, Activity
The table below presents the activity and other information on the outstanding stock options:
Stock Options OutstandingWeighted-Average Exercise Price Per ShareWeighted-Average Remaining Contractual Life (in years)Aggregate Intrinsic Value
Outstanding as of December 31, 2025
1,735,338 $2.80 7.56$4,684 
Exercised(36,489)1.84 
Expired(156,415)2.09 
Outstanding as of March 31, 2026
1,542,434 $2.86 7.60$1,628 
Vested and exercisable as of March 31, 2026
1,052,505 $2.74 7.10$1,423 
As of
March 31, 2026
Unrecognized compensation costs related to the stock options
$1,436 
Weighted average recognition period for unrecognized compensation costs
2.63 years
Schedule of Share-Based Payment Arrangement, Restricted Stock Unit, Activity
The table below presents the activity and other information on the outstanding RSUs:
RSUs
Outstanding		Weighted-Average Grant Date Fair Value Per Share
Unvested as of December 31, 2025
11,832,102 $2.73 
Granted6,262,159 3.58 
Vested(1,017,849)2.28 
Forfeited(221,334)2.50 
Unvested as of March 31, 2026
16,855,078 $3.08 
As of
March 31, 2026
Unrecognized compensation costs related to the RSUs
$46,268 
Weighted average recognition period for unrecognized compensation costs
2.45 years
Schedule of Share-Based Payment Arrangement, Performance Shares, Activity
The table below presents the activity and other information on the outstanding PSUs:
PSUs
Outstanding		Weighted-Average Grant Date Fair Value Per Share
Unvested as of December 31, 2025
2,830,998 $3.37 
Vested(1,040,410)3.84 
Forfeited(1,790,588)3.68 
Unvested as of March 31, 2026
— $— 
Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions
The table below presents the assumptions used to estimate the grant date fair value of the purchase rights under the ESPP:
December 1, 2025
Price of common stock on the grant date$6.05
Expected term (in years)0.5
Expected volatility(1)
110%
Risk-free rate of return3.75%
Expected annual dividend yield—%
Fair value of the award on the grant date$2.76
(1) Expected volatility is based on a combination of implied and historical equity volatility of selected reasonably similar publicly traded companies.
Schedule of Share-Based Payment Arrangement, Expensed and Capitalized, Amount
The table below presents the total equity-based compensation expense recognized for Class B Units, Stock Options, RSUs, PSUs, and ESPP in selling, general and administrative expense, cost of revenues, and research and development for the following periods:
Three Months Ended March 31,
20262025
Equity-based compensation expense in selling, general and administrative$1,997 $4,087 
Equity-based compensation expense in cost of revenues1,179 2,536 
Equity-based compensation expense in research and development247 777 
Total equity-based compensation expense$3,423 $7,400